Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...

Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Medtronic plc is rated a Buy, expecting 10-11% annual total returns, supported by 7-8% EPS growth. Learn more about MDT stock ...

Medtronic issues recall diabetes software affecting CareLink version 4.2B due to incorrect glucose data display, prompting clinician review.

Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Medtronic announced that results from the company-sponsored In.Pact Admiral drug-coated balloon (DCB) French Quality of Life ( ...

Though the Medtronic OmniaSecure is the world's smallest defibrillation lead, the product development story isn't one of ...

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The FDA’s initial clearance includes procedures to remove the prostate, kidneys ...

Even if that will be an important step for Medtronic, Intuitive Surgical should remain the top player and still outpace its challenger. For one, it will take a long time for Medtronic's Hugo to earn ...